Wilate 7.5 mg (Human Plasma Proteins POWDER FOR SOLUTION) 7.5 MG

WILATE 7.5 MG is a powder for solution containing human plasma proteins, used for intravenous administration. This medication is designed to support clotting factors in the blood, aiding in effective hemostasis.

Strength

7.5 MG

Pack Size

5ML

Manufacturer / TM Owner

OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

WILATE 7.5 MG is primarily used to manage bleeding episodes in patients with certain clotting factor deficiencies. It is often prescribed for conditions where the body's natural clotting mechanisms are impaired, helping to restore normal hemostatic function. This medication is formulated to provide rapid and effective support for clotting processes, making it a crucial tool in the management of bleeding disorders.

Side Effects

When administered intravenously, WILATE 7.5 MG works by supplementing the body's natural clotting factors. This can help reduce the frequency and severity of bleeding episodes. Patients may experience improved hemostasis, allowing for better management of conditions related to clotting factor deficiencies.

Precautions & Warnings

WILATE 7.5 MG should be handled with care, ensuring proper storage and preparation before administration. It is important to follow medical guidance for reconstitution and intravenous delivery. Patients with known allergies to human plasma proteins should exercise caution and consult their healthcare provider before use.

Avoid Interactions

WILATE 7.5 MG may interact with other medications that affect blood clotting. It is advisable to inform your healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Always consult a healthcare professional for personalized advice.

Frequently Asked Questions

WILATE 7.5 MG is used to manage bleeding episodes in patients with certain clotting factor deficiencies, supporting effective hemostasis.

WILATE 7.5 MG is administered intravenously after reconstitution as a powder for solution.

WILATE 7.5 MG helps reduce the frequency and severity of bleeding episodes by supplementing natural clotting factors.

Patients should follow medical guidance for proper storage, preparation, and administration, and consult a healthcare provider if they have allergies to human plasma proteins.

WILATE 7.5 MG may interact with medications that affect blood clotting, so it is important to inform your healthcare provider about all current medications.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.